Vascular Sealing Medical Glues

Global Vascular Sealing Medical Glues Market to Reach US$1.1 Billion by 2030

The global market for Vascular Sealing Medical Glues estimated at US$728.7 Million in the year 2024, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Revascularization, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$734.8 Million by the end of the analysis period. Growth in the Other Procedures segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$198.5 Million While China is Forecast to Grow at 10.3% CAGR

The Vascular Sealing Medical Glues market in the U.S. is estimated at US$198.5 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$220.1 Million by the year 2030 trailing a CAGR of 10.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Vascular Sealing Medical Glues Market – Key Trends & Drivers Summarized

Why Are Surgeons and Hospitals Shifting Toward Vascular Sealing Medical Glues?

Over the past decade, vascular sealing medical glues have increasingly gained traction across surgical suites, emergency care units, and trauma centers worldwide. Their rapid adoption stems from the growing clinical emphasis on reducing operative time, minimizing complications such as hemorrhage, and improving post-operative recovery outcomes. With conventional suturing and stapling methods proving insufficient or cumbersome in certain vascular procedures—especially in minimally invasive surgeries—medical glues are being positioned as viable, efficient alternatives. These glues offer targeted hemostasis and seamless tissue approximation, particularly beneficial during cardiovascular and neurovascular interventions where precision and rapid response are critical. Furthermore, the evolution of biocompatible and bioresorbable glue formulations has alleviated earlier concerns related to immune response and tissue damage, thus boosting surgeon confidence and patient safety.

How Are Regulatory Shifts and Biotech Innovation Reshaping the Competitive Landscape?

Global regulatory authorities such as the U.S. FDA and the European Medicines Agency have shown growing receptiveness to novel hemostatic agents, leading to a more streamlined approval process for vascular sealing glues. Simultaneously, investments in biomedical R&D have intensified, with both established med-tech giants and emerging biotech firms pouring resources into next-gen adhesive technologies. Innovations such as temperature-responsive glues, light-activated bonding agents, and synthetic mimics of naturally occurring fibrin and collagen have begun to redefine the product performance benchmarks. These scientific advancements not only offer stronger adhesion in high-pressure vascular environments but also support diverse anatomical applications. Patents and proprietary technologies now represent significant competitive differentiators, with market players racing to offer faster setting times, superior tensile strength, and improved bioabsorption profiles to gain regulatory and clinical acceptance.

Are End-Use Shifts in Surgical Practice Driving Market Realignment?

Yes—significant shifts in end-use preferences are causing a noticeable realignment in the vascular sealing glues market. The migration of complex surgical procedures to outpatient and ambulatory care centers—fueled by the global movement toward cost-effective healthcare delivery—has heightened the need for efficient, ready-to-use vascular sealing solutions. Concurrently, minimally invasive and robotic-assisted surgeries, which demand greater precision and minimal thermal damage to adjacent tissues, have pushed the demand for non-mechanical hemostatic methods. These shifts have also influenced procurement behaviors, with hospital networks and surgical facilities favoring glues that reduce operation time, eliminate the need for follow-up interventions, and integrate seamlessly with robotic surgical platforms. Furthermore, rising vascular surgery volumes, prompted by the aging global population and growing prevalence of lifestyle diseases like hypertension and diabetes, have broadened the addressable market for sealing agents across therapeutic areas including cardiology, oncology, and transplant surgery.

What Forces Are Powering the Expansion of the Vascular Sealing Medical Glues Market?

The growth in the vascular sealing medical glues market is driven by several factors that span technology innovation, shifting end-use preferences, and evolving healthcare infrastructure. One of the primary catalysts is the development of advanced polymeric and bioinspired adhesives that offer superior adhesion even in dynamic, blood-rich environments—a traditional challenge for older glue technologies. These innovations have strengthened the business case for integrating sealing glues in trauma surgery, cardiovascular procedures, and interventional radiology. Moreover, the increasing global penetration of minimally invasive surgery techniques has generated sustained demand for vascular glues, particularly in geographies where healthcare access is expanding. The rise of same-day discharge policies in surgical care is further amplifying interest in glues that reduce procedural time and post-op care. Also contributing to market momentum is the growing physician awareness and formal surgical training that includes exposure to vascular glue applications. On the systemic side, the proliferation of surgical infrastructure in emerging economies—coupled with favorable reimbursement frameworks and the rise of public-private healthcare partnerships—is opening up new adoption channels and expanding market accessibility. Together, these factors are not only sustaining but accelerating the global uptake of vascular sealing medical glues.

SCOPE OF STUDY:

The report analyzes the Vascular Sealing Medical Glues market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Procedure (Revascularization, Other Procedures); End-Use (Hospitals, Specialty Clinics, Ambulatory Surgery Centers)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Abbott Laboratories
• Adhex
• Advanced Medical Solutions
• Artivion, Inc.
• Baxter International Inc.
• Becton, Dickinson and Company
• Chemence Medical
• CSL Behring
• CryoLife, Inc.
• Ethicon (Johnson & Johnson)
• H.B. Fuller Medical Adhesive Technologies
• Henkel AG & Co. KGaA
• Integra LifeSciences
• Medtronic plc
• Pfizer Inc.
• Stryker Corporation
• Success Bio-Tech Co., Ltd.
• Terumo Corporation
• Tissuemed Ltd.
• TISSIUM

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.